Ameriprise
STIM icon

Ameriprise’s Neuronetics STIM Stock Holding History

Ameriprise’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-79,484
Closed -$1.27M – 3954
2021
Q2 		$1.27M Sell
79,484
-4,400
-5% -$60.8K ﹤0.01% 3121
2021
Q1 		$1.04M Buy
+83,884
New +$1.29M ﹤0.01% 3135
2019
Q4 		– Sell
-60,249
Closed -$501K – 3762
2019
Q3 		$501K Buy
60,249
+1,705
+3% +$18.6K ﹤0.01% 3302
2019
Q2 		$732K Buy
58,544
+10,405
+22% +$147K ﹤0.01% 3186
2019
Q1 		$734K Sell
48,139
-110
-0.2% -$1.82K ﹤0.01% 3160
2018
Q4 		$933K Buy
48,249
+110
+0.2% +$2.41K ﹤0.01% 2966
2018
Q3 		$1.54M Sell
48,139
-710
-1% -$21.6K ﹤0.01% 2908
2018
Q2 		$1.3M Buy
+48,849
New +$1.33M ﹤0.01% 2919

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Ameriprise's STIM Position: Q3 2021 in Review

Ameriprise sold out of Neuronetics (STIM) in Q3 2021, closing a stake of 79,484 shares — an estimated $1.27M sold.

Ameriprise first reported a position in STIM in Q2 2018 and held it in 8 quarters. The position peaked at $1.54M in Q3 2018. 97 funds tracked by Wall St. Rank hold STIM as of Q3 2021.

  • Ameriprise reported no remaining Neuronetics position as of Q3 2021 after selling out during the quarter.
  • Ameriprise sold 79,484 Neuronetics shares in Q3 2021, an estimated $1.27M.
  • Ameriprise first reported a position in Neuronetics in Q2 2018 and held it in 8 quarters.
  • Ameriprise's Neuronetics position peaked at $1.54M in Q3 2018.
  • 97 funds tracked by Wall St. Rank held Neuronetics as of Q3 2021.

Based on Ameriprise's 13F filing for Q3 2021, filed 15 Nov 2021.